New User Account Set Up

If you do not have an account with the Digest, please click on "Submit to the Digest." By logging in with your UCLA Login ID (formerly known as BOL Login), a new account will automatically be generated. If you experience any difficulties, please send an email to our help desk:


If you have any questions or concerns, please email our help desk/support team: We are more than happy to address any questions or concerns regarding the Weekly Message Digest system you may have.

How do I subscribe?

If you have a mednet email account (, you should already be subscribed.

If you do not have a mednet email account or you are not receiving the Digest, please send an email to and we will add you to our list.

Clinical Study: At-home treatment device for Major Depressive Disorder

Volunteers needed for Research Study on new at-home treatment device for Major Depressive Disorder

Depression is a common illness worldwide, with more than 264 millionpeople affected. Many depressed people do not get sufficient benefit from antidepressant medications and are seeking alternative treatment options. Are you one of them?

You may qualify to participate in a research study conducted by the UCLA Neuromodulation division at the UCLA Semel Institute to evaluate a new treatment for alleviating Major Depressive Disorder (MDD) symptoms that is self-administered with an investigational medical device. The study device is non-invasive and is used by participants at home at convenient times. Compensation for time and travel is available for eligible participants.

To learn more about participation, call: Nikita Vince-Cruz at (310) 825-4781 or email 


• Individuals between the ages of 18 and 70

• Currently experiencing an episode of depression

• Diagnosis of Major Depressive Disorder


Participation involves:

• Brain stimulation treatments administered at home

• Completion of up six (6) in-person visits

• Completion of weekly assessments about mood and mental well-being




Posting Information
This posting expired on February 20, 2022.
Posting Attachment: Download Attachment

Share this posting on social media!